Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Mechanism Comparison: GABA-A Modulation vs Serotonin Reuptake Inhibition

Lexapro increases synaptic serotonin concentration by blocking the SERT transporter protein that normally clears serotonin from the synaptic cleft. Over 14–21 days, this sustained elevation triggers downregulation of presynaptic autoreceptors (5-HT1A), which p

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Lexapro increases synaptic serotonin concentration by blocking the SERT transporter protein that normally clears serotonin from the synaptic cleft. Over 14–21 days, this sustained elevation triggers downregulation of presynaptic autoreceptors (5-HT1A), which paradoxically increases net serotonergic tone. The therapeutic effect emerges from adaptive changes, not acute serotonin elevation. This is why SSRIs require weeks to work and why stopping them abruptly causes discontinuation syndrome.
  • Selank works through GABA-A receptor expression upregulation and leucine-enkephalin metabolism modulation. Animal models demonstrate that selank increases GABA-A receptor subunit mRNA expression in the hippocampus and cortex, enhancing inhibitory neurotransmission without direct agonism. The peptide also inhibits enkephalinase, the enzyme that degrades leucine-enkephalin. Raising endogenous opioid peptide levels that produce anxiolytic effects independent of benzodiazepine or serotonin pathways. Onset is immediate because the mechanism doesn't require receptor adaptation. Selank modulates existing receptor populations rather than forcing compensatory changes.
  • The amidate modification replaces selank's C-terminal carboxyl group with an amide group, dramatically reducing susceptibility to carboxypeptidase degradation. Standard selank has a plasma half-life of approximately 25 minutes; selank amidate extends this to several hours, maintaining therapeutic peptide concentrations long enough to produce sustained receptor engagement. This structural change doesn't alter the binding mechanism. It just keeps the peptide intact longer.
  • SSRI therapy requires continuous daily dosing to maintain SERT inhibition. Miss three days and serotonin reuptake normalises within 72 hours. Selank's effect is immediate but transient. Receptor modulation persists only while peptide concentration remains above threshold. Neither is inherently superior; they represent different trade-offs between onset speed and duration of effect.